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INTRODUCTION
In 2010, the Society of Critical Care Medicine organized a task force to raise awareness of 
the long-term cognitive, psychological, and physical impairments in survivors of critical 
illness. Impairments in these three domains are collectively known as post-intensive care 
syndrome (PICS).1 PICS affects 50–70% of intensive care unit (ICU) survivors, and its 
effects can persist for 5–15 years after ICU hospitalization.2 One major barrier in the 
assessment of PICS is the lack of a single, validated clinical tool to rapidly assess 
impairments in all three domains of PICS.1
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The Healthy Aging Brain Care Monitor Self Report version (HABC-M SR) is a 27-item 
questionnaire that evaluates cognitive, functional, and psychological domains3 (Figure 1). 
Patients demarcate the frequency of target symptoms (cognitive, psychological, and 
functional) in the past 2 weeks. The HABC-M SR can be administered face to face, over the 
phone, or via the Internet. It has been validated in older patients with normal cognition, mild 
cognitive impairment, early-stage dementia, and late-life depression. The aim of this study 
was to validate face to face administration of the HABC-M SR as a rapid assessment tool for 
PICS.
MATERIAL AND METHODS
Subjects and Setting
A total of 261 patients were recruited from July 2011 to May 2017 at the Critical Care 
Recovery Center (CCRC) at Eskenazi Hospital, one of the first ICU adult survivor clinics in 
the United States.4 Eskenazi Hospital serves a racially diverse, underserved population in the 
Indianapolis metropolitan area. Inclusion criteria were that patients needed to be 18 years or 
older, admitted to the Eskenazi ICU, on mechanical ventilation or delirious for >48 hours, 
recommended for follow-up by a critical care physician, and had a Mini-Mental State 
Examination (MMSE) greater than 17. Exclusion criteria were enrollment in hospice or 
palliative care services. Patients who did not have an HABC-M SR (n = 86) or 
neuropsychological testing (n = 33) were also excluded from the study. The final sample 
included a subgroup of 142 patients who completed both the HABC-M SR and the 
standardized assessments. Standardized assessments were done at the initial visit, and the 
HABC-M SR was completed within a week or less during the same visit or a subsequent 
follow-up visit (with a mean gap of 7.2 days ± 10.0). Standardized assessments included 
those to examine cognition (either CERAD or RBANS), psychological symptoms (PHQ-9 or 
Geriatric Depression Scale; PTSS-10; and GAD-7), and functional levels (PSMS and IADL 
self-report). We chose to utilize the CERAD and GDS-15 during the initial assessments 
since these tests had been validated with the HABC-M SR, but as the CCRC referral base 
began to include younger ICU survivors, we decided to switch the cognitive and depression 
assessments to the RBANS and PHQ-9, respectively. The PSMS and IADL self-ratings can 
be used across all age ranges. Institutional Review Board approval was obtained to conduct 
retrospective analysis of de-identified clinical data.
Healthy Aging Brain Care-Monitor Self Report (HABC-M SR)
The HABC-M SR was developed by an interdisciplinary panel of dementia experts, and was 
validated in patients with a MMSE score greater than 17.3 The HABC-M SR 
(Supplementary Data, Table 1) is a 27 item self-administered tool to evaluate the cognitive, 
functional, and psychological symptoms. The cognitive subscale was composed of 6 
questions about memory, orientation, and judgment. The functional subscale was composed 
of 11 questions about instrumental activities of daily living (IADLs) and activities of daily 
living (ADLs). The psychological subscale was composed of 10 questions about depression, 
psychotic, and anxiety symptoms. Each question is rated on the patient’s perceived 
frequency of the symptom over the past two weeks: 0 = Not at all (0–1 day), 1 = Several 
Days (2–6 days), 2 = More than half the days (7–11 days), 3 = Almost daily (12–14 days). 
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The maximum scores for cognitive, functional, and psychological subscales are 18, 33, and 
30 respectively. The maximum total score is 81. Higher numbers for the three subscales and 
the total score correlate with higher severity of symptoms.3
Standardized Assessments of Cognition
All patients completed the MMSE, a 30 point questionnaire which assesses for cognitive 
impairment.5 They also completed the Trail Making Test (TMT), which consists of 2 parts to 
measure processing speed (TMT-A) and executive functioning (TMT-B).6 The amount of 
time to complete each part is the score. In TMT-A, the patient sequentially connects 25 
encircled numbers distributed on a sheet of paper. In TMT-B, the patient connects alternating 
between numbers and letters in ascending order (e.g., 1, A, 2, B, 3, C, etc.). Patients then 
completed either the Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS) or the Consortium to Establish a Registry for Alzheimer’s Disease 
Neuropsychological Battery (CERAD-NB). The RBANS is a neuropsychological screening 
tool validated in a wide range of neuropsychiatric disorders.7,8 It yields five index scores 
(attention, language, visuospatial/constructional abilities, immediate memory, and delayed 
memory) and a Total Scale score (40–160 points). The CERAD-NB is a standardized test 
battery designed to detect cognitive deficits in Alzheimer’s dementia.9 It consists of 8 
subtests (verbal fluency, Boston naming, mini-mental state exam, word list learning, 
constructional praxis, word list recall, word list recognition, and constructional praxis recall) 
which measure general cognition, semantic fluency, graphomotor construction ability, 
confrontation naming, and verbal learning and memory.
Standardized Assessments of Psychological Symptoms
All patients completed either the Geriatric Depression Scale-30 (GDS-30) or the Patient 
Health Questionnaire-9 (PHQ-9) to assess depressive symptoms. The GDS-30 is a 30-item, 
self-report, yes/no assessment to measure depression in the elderly.10 The PHQ-9 is a 9-
question self-administered scale where patients rate frequency of depressive symptoms on a 
0–3 scale (0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day) 
over the past two weeks.11 A subset of patients also completed the Post-Traumatic Symptom 
Scale (PTSS-10), a 10 item self-report post-traumatic stress disorder (PTSD) screen with a 
total severity score ranging 10–70. The items are based on the Diagnosis and Statistical 
Manual of Mental Disorders (DSM)-III criteria for PTSD. The PTSS-10 has since been 
validated in patients with acute respiratory distress disorder after ICU treatment using the 
Structured Clinical Interview for DSM-IV.12
Standardized Assessments of Physical Functioning
Patients or informal caregivers completed the Physical Self-Maintenance Scale (PSMS), a 6 
item questionnaire that assesses the patient’s ability to complete the activities of daily living 
(ADLs).13 The patient’s level of functioning for independent activities of daily living 
(IADLs) was also assessed with a modified version of the Lawton IADL scale; participants 
were asked to rate on a three point Likert scale (1 = completely independent to 3 = 
completely dependent) on seven IADLs (their ability to telephone, traveling, shopping, 
preparing meals, housework, medication management, and finances).
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Data Collection
At the initial visit, the critical care physician completed a history and interview with both the 
patient and informal caregiver (if one was available) and performed a full physical 
examination including vitals and a neurologic examination. A healthcare professional or 
psychometrist administered the HABC-M SR and the standardized assessments of cognition, 
psychological symptoms, and functional symptoms as described above. Medical history and 
medication lists were collected from patients, informal caregivers, and electronic medical 
records.
Statistical Analysis
Internal consistency of the scale items was assessed using Cronbach’s alpha. Convergent-
divergent validity was assessed performing two separate analyses. First, the relationship 
between the HABC-M SR scales and standardized cognitive, psychological, and functional 
scales was examined. It was expected that the individual scales from the self-report would 
correlate highest with the external scales that belonged to the same domain (e.g. the HABC-
M SR psychological scale would correlate with the GDS-30, PHQ-9, PTSS-10). Then 
generalized linear models were used to test whether this association remained significant 
after adjusting for age, gender, and education. Results for the HABC-M SR from the CCRC 
cohort were then compared to the sample used in the original validation study for the 
HABC-M SR. Patients for the original validation study for the HABC-M SR were recruited 
if they had 1) at least one visit to primary care during the period from January 1, 2008 to 
April 1, 2011, 2) were age ≥65 years, and 3) had either a diagnosis of cognitive impairment 
or had received at least one prescription of a cholinesterase inhibitor or memantine or had 
any ICD-9 code indicating depression or had received at least one prescription of a selective 
serotonin reuptake. Fisher’s exact test was used to test for differences in percentage of 
patients at the floor of each scale, while the Mann-Whitney test was used to test for 
differences in scale scores across the two populations. All statistical analyses were 
performed using the SAS 9.4 version (Cary, NC).
RESULTS
Patient characteristics
Characteristics of the study patients are shown in Table 1. The average age was 52.3 years 
(standard deviation (SD) 13.0), and less than half (48%) were female. The cohort reflected 
the diversity of the Indianapolis metropolitan area. Nearly half were African American 
(46%), and the average education was 11.8 years (SD 2.3). The most common comorbidities 
were hypertension (70%), alcohol use disorder (67%), chronic obstructive pulmonary 
disease (COPD) or other lung disease (46%), and depression (46%). In terms of 
hospitalization characteristics, the mean length of ICU stay was 9 days and the mean length 
of hospital stay was 17.1 days. 46% of the patients had an episode of ICU delirium. Most 
patients (94%) required ventilator support during their ICU stay.
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Reliability and scale score features of HABC-M SR
Table 2 shows the internal-consistency reliability and score distributions of the HABC-M 
SR. The internal consistency of the HABC-M SR scales was good to excellent (0.83–0.92). 
All the subscale and total scores were positively distributed, but still covered a wide range of 
possible answers. The interscale correlation between all of the subscales was moderate 
(0.61–0.70) (Supplementary Table 1), but indicated that the subscales were distinct.
Construct validity of HABC-M SR
Table 3 shows the construct validity of the subscale and total scores in HABC-M SR. The 
psychological subscale had the strongest correlations with the standardized measures of 
psychological symptoms, PHQ-9 (Spearman correlation coefficient 0.73) (n = 67), GDS-30 
(0.74) (n = 56), and PTSS-10 (0.68) (n = 59). The cognitive subscale strongly correlated 
with only the delayed memory measure of the CERAD-NB (−0.51) (n = 56), but did not 
correlate with any of the measures on the RBANS (n = 76). The functional subscale 
correlated with the PSMS (−0.26). All these relationships remained significant after 
adjusting for age, gender, and education.
Comparison of HABC-M SR between CCRC and primary care populations
Table 4 compares the subscale and total HABC-M SR scores of CCRC patients to primary 
care patients (n = 291; mean age 72.7 years ± 6.7). The CCRC patients had significantly 
worse scores for all subscales and total scale on HABC-M SR. The average total HABC-M 
SR score for CCRC patients was nearly double the total score for patients seen in primary 
care. These relationships remained significant after adjusting for age and gender. Patients 
seen in primary care were more likely to report no cognition, psychological, and functional 
symptoms compared to the patients seen in the CCRC (Supplementary Table 2).
DISCUSSION
While epidemiologic studies suggest a fairly high prevalence of PICS in the post-ICU 
population, this syndrome remains underrecognized.1,2 One major barrier to the recognition 
of PICS is that it affects multiple domains (physical, psychological, cognition). In today’s 
era of subspecialized care, the full spectrum of the symptomology may not be captured in 
the post-hospital setting. Therefore the need for a clinical tool that rapidly assesses all these 
domains is much needed. Our findings suggest that the HABC-M SR may be such a clinical 
tool. The HABC-M SR psychological and functional subscales were found to be reliable 
tools to measure the severity of symptomology in PICS. Although the HABC-M cognitive 
scale demonstrated low correlations with the cognitive performance measures, the highest 
correlation was with the CERAD Delayed Memory, which is the area most related 
conceptually to the HABC-M SR cognitive scale. This suggests that the cognitive subscale 
in PICS may have limited validity.
Despite this limitation of HABC-M SR, patients seen in the CCRC still reported higher 
severity of cognitive, psychological, and functional symptoms compared to the patients seen 
in primary care. Although our population is much younger than the original targeted 
population for the HABC-M SR, a number of studies have suggested that despite their 
Wang et al. Page 5
Am J Crit Care. Author manuscript; available in PMC 2020 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
chronological age, younger ICU survivor patients may be suffering from the insults of aging 
similar to those seen in older patients, including significant cognitive deficits. Therefore, 
clinicians may consider having ICU survivors who report cognitive symptoms to undergo 
more detailed neuropsychological testing. However, normal cognitive subscale scores should 
not deter clinicians from doing further evaluation if they have concerns about patients’ 
cognition based on their history and examination.
Most importantly, this study lays the groundwork for future development of self-report 
cognitive scales in PICS, similar to those being developed and studied for AD. While 
neuropsychological assessment (an interview with a reliable informant and full testing 
battery) remain the gold standard for a cognitive disorders workup, there are significant 
logistical and resource barriers to administering neuropsychological assessments on a wide 
scale. The HABC-M SR cognitive subscale was modeled after the brief self-report and 
informant report tools used for mild cognitive impairment and early Alzheimer’s disease, 
such as the Cognitive Change Index14 and the Measurement of Everyday Cognition15, and 
additional work will be needed to refine and validate a self-report or informant-based 
screening tool for cognitive symptoms in PICS. Having reliable cognitive screening tools 
can then help clinicians decide who to appropriately refer for further assessment.
Future studies will need to examine whether the cognitive subscale of the HABC-M 
caregiver version is a reliable tool which can accurately capture the severity of cognitive 
symptoms in PICS. The gold standard for cognitive assessment consists of a clinical 
interview and detailed neuropsychological battery. Despite the lack of correlation between 
detailed cognitive testing and cognitive subscale score, there is still some relative value since 
patients in the CCRC did report more cognitive symptoms than patients in primary care.
The major strength of our study is that we have demonstrated that the HABC-M-SR, an easy 
to use, standardized clinical tool, has potential as a screening tool to rapidly assess the wide 
range of symptoms seen in PICS. Many other studies have utilized a wide range of tools to 
measure psychological symptoms, cognitive performance, and physical functioning.16–20 
These tools can be time-intensive, may require additional training for health care 
professionals to administer, and are often used in the research setting involving subspecialty 
care. It requires little to no training for health care professionals to administer, can be 
completed within 5 minutes, and can be administered in a wide range of health care settings 
(primary care and subspecialty outpatient care). The HABC-M SR can also be repeated for 
longitudinal follow-up of these symptoms. While the number of ICU survivor clinics is 
rapidly growing, access to this subspecialty care remains quite limited. Developing a tool to 
be able to rapidly screen ICU survivors for these symptoms in other settings (most notably 
in primary care) can increase the likelihood that ICU survivors are referred to the 
appropriate subspecialty care that they need.
There are some limitations to our study. First, the HABC-M SR can only be administered in 
patients with normal cognition, mild cognitive impairment, or early stage dementia. Future 
studies will need to examine whether the caregiver version of the HABC-M will be a valid 
measure of symptoms of PICS in patients with moderate to severe dementia. Patients who 
screen negative on HABC-M SR are less likely to have symptoms suggestive of PICS, but 
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clinicians should always interpret HABC-M SR, as with all screens, in the context of the 
patients’ history and physical examination. Second, the HABC-M SR was administered in a 
subspecialty ICU survivor clinic. ICU survivor clinics are more common in Europe, but still 
fairly rare in the US, which means many ICU survivors rely on primary care physicians for 
hospital discharge follow-up. Although additional studies are need to validate this screen in 
larger populations and on longitudinal follow-up, clinicians may find the HABC-M SR 
helpful as a screen for symptoms in ICU survivors and follow-up with additional history and 
examination as indicated. Although the HABC-M SR has been used in older patients in 
primary care who had concerns for mild cognitive impairment, early stage dementia, or late-
life depression, it has not been used in primary care to screen younger ICU survivors who 
may have undetected cognitive, mental health, or functional symptoms that could suggest a 
diagnosis of PICS. Future studies will need to examine whether primary care practitioners 
can accurately administer the HABC-M SR for ICU survivors, and then appropriately 
diagnose and refer for the management of PICS based on the results of the HABC-M SR. 
The HABC-M SR is a clinical tool that can be administered through multiple modalities 
(face to face, over the phone, and via the internet). Future studies will need to validate 
whether alternative modalities of administration of the HABC-MR SR via telephone or 
internet show similar results. Other limitations include that the functional subscale does not 
directly correlate with the physical impairments in PICS and selection bias in terms of 
patients who participate in this study.
CONCLUSION
As the number of ICU survivors increases, PICS is now becoming a major public health 
issue. Post discharge care for these survivors is fragmented.21 Despite the growth of ICU 
survivor clinics, the majority of ICU survivors will also continue to receive their care in 
primary care.21,22 Therefore, healthcare professionals in all disciplines and specialties need 
clinical assessment tools for PICS that can be used in a wide range of outpatient settings. 
The use of such tools allow healthcare professionals to recognize patients are experiencing 
the symptoms of PICS and then referring to critical care or other relevant subspecialty 
expertise for the management of PICS. These tools need to be short and easy for healthcare 
professionals with little to no expertise in PICS to use. The HABC-M SR is one such tool, 
and future studies will need to examine potential barriers to the adoption of HABC-M SR in 
the outpatient settings for the diagnosis of PICS.
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Figure 1. 
HABC-Monitor. Self-Report Version.
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Table 1.
Characteristics of Patients with Post-Intensive Care Syndrome (PICS).
Demographics
Mean age in years (SD) 52.3 (13.0)
Mean years of education (SD) 11.8 (2.3)
Female, N (%) 68 (47.9)
Race
 African-American N (%) 64 (45.7)
 Other N (%) 9 (6.4)
 White N (%) 67 (47.9)
Comorbidities
Alcohol use disorder (current or previous), N (%) 58 (40.8)
Tobacco use disorder (current or previous), N (%) 112 (78.9)
History of depression, N (%) 64 (46.0)
CNS disorder, N (%) 36 (26.1)
Cardiac disease, % N (%) 48 (34.8)
Hypertension, % N (%) 97 (70.3)
Diabetes mellitus, N (%) 38 (27.5)
COPD and other lung disease, % N (%) 64 (46.4)
Cancer, N (%) 20 (14.5)
Hospital characteristics*
Mean Length of hospitalization days (SD) 17.1 (15.5)
Length of ICU days (SD) 12.2 (13.1)
Delirium during entire hospitalization, N (%) 63 (45.7)
Respiratory failure, N (%) 129 (93.5)
Initial CCRC visit information
Time between initial visit in CCRC and discharge from the hospital (days) 89.3 (54.2)
N = 142 for patients with PICS.
Continuous variables were expressed as average (SD). Dichotomous variables were expressed as % (N).
ǂ
History of depression was defined as a diagnosis of depression based on informant report or chart diagnosis of depression.
*
Hospital stay with sentinel ICU stay resulting in CCRC referral
Central nervous disease (CNS). Chronic obstructive pulmonary disease (COPD). Critical Care Recovery Center (CCRC). Intensive care unit (ICU). 
Post-intensive care syndrome (PICS). Standard deviation (SD).
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Table 2.
HABC-M SR score features: internal-consistency reliability and score distributions
HABC-M SR
Scales
# of
Items
Cronbach’
s Alpha
# of
possible
levels
Range Mean Median SD %
Floor
%
Ceiling
Cognitive   6 0.83 18 0–15   3.7 2 4.1 33.3 0.0
Functional 11 0.83 33 0–24.75   6.3   3.3 6.8 25.0 0.0
Psychological 10 0.84 30 0–22   6.4   5.0 6.0 20.1 0.0
Total 27 0.92 81 0–57.75 16.3 12.5 14.5 12.3 0.0
Internal consistency of the scale items was assessed using Cronbach’s alpha. Healthy Aging Brain Center Monitor Self-Report (HABC-M SR). 
Standard deviation (SD).
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Table 3.
Construct validity of HABC-M SR in CCRC patients
External Scales Cognitive
Score
Functional
Score
Behavioral /
Psychological
Score
Total Score
Cognitive Measures
MMSE −0.08 −0.11 −0.06 −0.09
RBANS (n = 76)
 Total −0.20
  −0.24* −0.12 −0.22
 Immediate Recall −0.20 −0.20 −0.11 −0.19
 Visuospatial −0.21 −0.20 −0.18
  −0.25*
 Language   0.06   0.04   0.09   0.07
 Attention −0.16 −0.21 −0.08 −0.16
 Delayed Memory −0.20 −0.22 −0.06 −0.19
 Trail A −0.14 −0.15 −0.08 −0.14
 Trail B −0.10 −0.17   0.14 −0.07
CERAD-NB (n = 56)
 Fluency
  −0.38* −0.19 −0.05 −0.19
 Naming −0.22 −0.16 −0.04 −0.18
 Praxis −0.06 −0.18   −0.002 −0.12
 Delayed Memory
    −0.51**   −0.42* −0.18   −0.40*
 AMNART −0.18 −0.11 −0.23 −0.18
 Delayed Praxis −0.25
  −0.27* −0.11 −0.25
 Tokens
  −0.35* −0.26 −0.18   −0.33*
 Trails A −0.02 −0.19   0.02 −0.09
 Trails B −0.07 −0.05   0.01 −0.04
Psychological Measures
PHQ-9 (n = 67)
    0.59**     0.38*      0.73**      0.58**
GDS-30 (n = 56)
    0.65**       0.51**      0.74**      0.70**
PTSS-10 (n = 59)
    0.45**     0.34*      0.68**      0.54**
Functional Measures
PSMS (n = 116)
  −0.19*   −0.26*  −0.16   −0.22*
Number of independent IADLs (n=109) −0.17
  −0.26*   −0.20*   −0.23*
Values represent Spearman correlation coefficients. Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Battery 
(CERAD-NB). Care Recovery Center (CCRC). Patient Health Questionnaire-9 (PHQ-9). Geriatric Depression Scale-30 (GDS-30). Instrumental 
Activities of Daily Living (IADL). Mini-Mental State Examination (MMSE). Physical Self-Maintenance Scale (PSMS). Post-Traumatic Symptom 
Scale (PTSS-10). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
*P < 0.05.
**P < 0.001.
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Table 4.
Comparison of HABC-M scores in CCRC and primary care populations.
CCRC Population
(n =142)
Primary Care Population
(n = 291)
Mean (SD) Median (IQR) Mean (SD) Median (IQR) P-value
Cognitive 3.7 (4.1)   2 (0–6) 1.9 (2.9) 0 (0–3) <0.001
Psychological 6.4 (6.0)   5 (1–11) 3.2 (4.2) 2 (0–5) <0.001
Functional 6.3 (6.8)   3.3 (0.6–11) 3.2 (4.5) 2 (0–5) <0.001
Total 16.3 (14.5) 12.5 (3.2–27.6) 8.3 (10.3)   4 (1–12) <0.001
Mann-Whitney test was used to test for differences in scale scores across the two populations.
Critical Care Recovery Center (CCRC). Healthy Aging Brain Center Monitor (HABC-M). Interquartile range (IQR). Standard deviation (SD).
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